Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05085730 · ClinicalTrials.gov registry record · NA
Assessment Skin Quality and Efficacy of Dermal Line After Four Bipolar Radiofrequency Microneedling Treatments
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT05085730 is a NA study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 13 participants.
The verdict
NCT05085730, a NA study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
This study intends to evaluate the safety and effectiveness of the InMode Morpheus8 System to treat facial and neck skin and assess its effect on skin quality and dermal lines. This device has been FDA cleared for full body subdermal adipose tissue remodeling.
Interventions
- DEVICE InMode Morpheus8 System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2022-01-14 |
| Est. Completion | 2022-12-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05085730
The ClinicalTrials.gov registry entry for NCT05085730 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which InMode Morpheus8 System is the first listed.
NCT05085730 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05085730 about?
NCT05085730 is a clinical study titled "Assessment Skin Quality and Efficacy of Dermal Line After Four Bipolar Radiofrequency Microneedling Treatments". This study intends to evaluate the safety and effectiveness of the InMode Morpheus8 System to treat facial and neck skin and assess its effect on skin quality and dermal lines. This device has been FDA cleared for full body subdermal adipose tissue remodeling.
What is the current status of trial NCT05085730?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2022-01-14. Estimated completion is 2022-12-22.
What interventions are being tested in trial NCT05085730?
The interventions under investigation include: InMode Morpheus8 System (DEVICE).
Who is sponsoring clinical trial NCT05085730?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.